Amsterdam, Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced the launch of EPIQ ultrasound system, offering an entirely new level of clinical confidence with a first-of-its-kind ultrasound architecture that is a totally new approach to creating ultrasound images without compromise. Making its debut at the European Society of Cardiology (ESC) 2013 Congress in Amsterdam, EPIQ features a new imaging technology called nSIGHT that when combined with Philips’ Anatomical Intelligence technology, delivers a powerful combination of speed and image clarity.
For the first time, Anatomical Intelligence – a rich data base of anatomic structural models and adaptive system technology – has been built into an ultrasound system creating an ultrasound system capable of efficiently producing more definitive clinical results. Anatomical Intelligence provides advanced organ modeling, image slicing, and proven quantification, making exams easier to perform, more reproducible, and delivering new levels of clinical information. Combining this intelligent technology with the precision clarity of nSIGHT Imaging makes for a faster more intuitive ultrasound system.
With EPIQ, Philips has created a ground-breaking platform that supports segment specific innovations for Cardiology, Radiology, OB/GYN and General Imaging:
Philips, known for its expertise in imaging technologies, has created a revolutionary imaging architecture, nSIGHT, a completely new way to form ultrasound images which allows:
“Philips is at the forefront of imaging technology innovation, and with EPIQ, we are pioneering a way to address significant imaging issues faced by medical professionals in the clinical setting,” said Gene Saragnese, CEO Healthcare Imaging Systems, Philips Healthcare. “The combination of Anatomical Intelligence and the use of nSIGHT Imaging technology is a major milestone in the history of ultrasound technology.”
“The image quality of EPIQ is truly impressive,” said Roberto Lang, MD, Director of Cardiac Imaging and Professor of Medicine, University of Chicago. “I also appreciate the numerous design elements that make EPIQ easier to operate including the standby battery, easy to connect transducers, and portability; it is clear that EPIQ is a system built for today’s healthcare environment.”
“As the population continues to age, diagnosing potentially life- threatening conditions early is critical. EPIQ complements the need for early detection by providing the technology and reliability that physicians require to make accurate diagnoses quickly and with greater confidence,” added Saragnese.
Other features of the EPIQ premium ultrasound system include:
A new best-in-class ergonomic design
Improved image quality
For more information, please follow this link or stop by the Philips booth (A300) at the ESC 2013 Congress event beginning Saturday, Aug. 31, running through Wednesday, Sept. 4 to learn more about EPIQ or speak with a Philips representative on site at ESC.
Senior Manager Philips Healthcare Tel: +31 6 10 55 8116 Email: Joost.Maltha@philips.com
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.